Tilray Brands Acquires HelloMD to Build Integrated Medical Cannabis Platform
Tilray Brands is buying HelloMD to expand patient access and digital healthcare capabilities, creating a vertically integrated medical cannabis framework in Canada.
Tilray Brands announced Monday it is acquiring HelloMD, a digital healthcare platform, in a move designed to deepen patient access to medical cannabis and cement the company's position as a vertically integrated operator in Canada's regulated cannabis market.
The deal hands Tilray direct control over a digital gateway that connects patients with healthcare practitioners and cannabis products, eliminating a key intermediary layer in its Canadian medical business. By folding HelloMD's telemedicine and patient-management infrastructure into its existing operations, Tilray aims to own every step of the supply chain — from cultivation and processing through to clinical consultation and product fulfillment.
Read more Apple Pushes Early Software Updates to Combat AI Cybersecurity Risks →
The acquisition also signals Tilray's broader ambition to strengthen its global medical cannabis platform at a time when international markets, particularly in Europe, are showing increased regulatory openness to cannabis-based medicines. A robust digital healthcare backbone in Canada could serve as a replicable model for expansion abroad, giving the company a template to deploy in newly liberalizing markets.
For Canadian patients, the practical effect could mean streamlined access to medical authorizations and product recommendations through a single integrated digital experience, rather than navigating separate clinical and retail touchpoints. Tilray has positioned the move as patient-centric, emphasizing expanded access rather than purely commercial consolidation.
Financial terms of the HelloMD acquisition were not disclosed in the announcement. Continue reading at GlobalNewswire.
